Indication
Dermatitis herpetiformis
Dermatitis herpetiformis is a chronic, relapsing autoimmune blistering dermatosis that serves as the primary cutaneous manifestation of gluten-sensitive enteropathy (celiac disease). Read more about Dermatitis herpetiformis
347 drugs 166 manufacturers
Drugs that treat it
Common Dermatitis herpetiformis therapies.
PREDNISONE
HYDROCORTISONE
METHYLPREDNISOLONE
PREDNISONE
TRIAMCINOLONE ACETONIDE
METHYLPREDNISOLONE ACETATE
BETAMETHASONE SOD PHOS-ACETATE (betamethasone acetate/betamethasone sodium phosphate)
DEXAMETHASONE
News & literature
Coming soonRelated codes
Coming soonRelated conditions & guidelines
Coming soonDermatitis herpetiformis is a chronic, relapsing autoimmune blistering dermatosis that serves as the primary cutaneous manifestation of gluten-sensitive enteropathy (celiac disease).
Primarily affecting adults and most frequently presenting in individuals of northern European ancestry, it targets the integumentary system while reflecting systemic immune dysregulation triggered by dietary gluten.
Clinically, it is characterized by intensely pruritic, grouped papulovesicular eruptions distributed symmetrically over extensor surfaces, including the elbows, knees, buttocks, and posterior scalp.
Pathophysiologically, the disorder is defined by circulating IgA antibodies against transglutaminases, leading to pathognomonic granular IgA deposits in the superficial dermal papillae that recruit neutrophils and form subepidermal microabscesses.
- nih.gov
Dermatitis herpetiformis is a chronic, relapsing autoimmune blistering dermatosis that serves as the primary cutaneous manifestation of gluten-sensitive enteropathy (celiac disease)
- nih.gov
Dermatitis herpetiformis is a chronic, relapsing autoimmune blistering dermatosis that serves as the primary cutaneous manifestation of gluten-sensitive enteropathy (celiac disease) Primarily affecting adults and most frequently presenting in individuals of northern European ancestry, it targets the integumentary system while reflecting systemic immune dysregulation triggered by dietary gluten
- cyberderm.net
Primarily affecting adults and most frequently presenting in individuals of northern European ancestry, it targets the integumentary system while reflecting systemic immune dysregulation triggered by dietary gluten Clinically, it is characterized by intensely pruritic, grouped papulovesicular eruptions distributed symmetrically over extensor surfaces, including the elbows, knees, buttocks, and posterior scalp Pathophysiologically, the disorder is defined by circulating IgA antibodies against tra...
- merckmanuals.com
Clinically, it is characterized by intensely pruritic, grouped papulovesicular eruptions distributed symmetrically over extensor surfaces, including the elbows, knees, buttocks, and posterior scalp Pathophysiologically, the disorder is defined by circulating IgA antibodies against transglutaminases, leading to pathognomonic granular IgA deposits in the superficial dermal papillae that recruit neutrophils and form subepidermal microabscesses
Personalize your experience
Follow Dermatitis herpetiformis and get updates as they land.
Already a member? Sign in
Follow an indication and get alerts when its drugs, labels, or guidelines change
Save any drug on this page to your favorites, synced across devices
AI-curated peer-reviewed research, summarized for your specialty
A morning digest of indication-relevant updates, when you want it
Sign in to follow this indication
Following an indication requires a free Physicians Office Resource account.